TipRanks
Go Ultimate55% OFF

Damian Lismore Insider Profile

4 Followers

Damian Lismore, CFO at Nexvet Biopharma, holds 43.88K shares in Nexvet Biopharma (Ticker: NVET).

Damian Lismore's Trading History

NVET
Nexvet Biopharma
Aug 02, 2017―Uninformative Sell723.83K$294.90K
NVET
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 02, 2017Uninformative Sell$723.83K107,713$6.72―
Feb 22, 2016Informative Buy$16.05K5,000$3.21+13.80%
Nov 23, 2015Informative Buy$720.006,000$0.12+2.90%
Nov 18, 2015Informative Buy$849.607,080$0.12+4.00%
Jul 02, 2015Informative Buy$480.004,000$0.12-1.40%

You May Also Like

Damian Lismore insider profile FAQ

What is the percentage of profitable transactions made by Damian Lismore?
The percentage of profitable transactions made by Damian Lismore is 75%.
What is the average return per transaction made by Damian Lismore?
The average return per transaction made by Damian Lismore is 4.80%.
What stocks does Damian Lismore hold?
Damian Lismore holds: NVET stocks.
What was Damian Lismore’s latest transaction?
Damian Lismore’s latest transaction was an Uninformative Sell of $723.83K.
What was Damian Lismore's most profitable transaction?
Damian Lismore’s most profitable transaction was an Informative Buy of NVET stock on February 22, 2016. The return on the trade was 13.80%.
What is Damian Lismore's role in Nexvet Biopharma?
Damian Lismore's role in Nexvet Biopharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.